INO (INO): Results for Last 10 Financial Years (Summary)

Inovio Pharmaceuticals, Inc.

NASDAQ (USD): Inovio Pharmaceuticals, Inc. (INO)

Last Price

1.88

Today's Change

+0.01 (0.53%)

Day's Change

1.81 - 1.92

Trading Volume

333,297

Financial

Market Cap

69 Million

Shares Outstanding

36 Million

Latest Quarter

31-Dec-2024 [Q4]

Announcement Date

18-Mar-2025

Reported Currency

USD

Revenue QoQ | YoY

- | 13.59%

NP QoQ | YoY

99.92% | 22.48%

Latest Audited

31-Dec-2024

Announcement Date

18-Mar-2025

Reported Currency

USD

Revenue | Net Profit

217,756.00 | -107,254,126.00

EPS | EPS Diluted

-3.95 Cent | -3.95 Cent

YoY

20.62%

NP Margin

-49,254.27%

Reported Currency in USD

Show?

YoY %

Horiz. %

	31/12/24	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	CAGR
Last 10 FY Result (Thousand)
Revenue	218	832	10,262	1,775	7,411	4,112	30,482	42,220	35,368	40,572	-44.01%
YoY %	-73.80%	-91.89%	478.14%	-76.05%	80.23%	-86.51%	-27.80%	19.37%	-12.83%	-	-
Horiz. %	0.54%	2.05%	25.29%	4.37%	18.27%	10.14%	75.13%	104.06%	87.17%	100.00%	-
PBT	-107,254,126	-135,117	-277,653	-303,224	-162,890	-120,809	-94,798	-88,206	-73,740	-31,201	146.92%
YoY %	-79,278.71%	51.34%	8.43%	-86.15%	-34.83%	-27.44%	-7.47%	-19.62%	-136.34%	-	-
Horiz. %	343,752.21%	433.05%	889.88%	971.84%	522.07%	387.20%	303.83%	282.70%	236.34%	100.00%	-
Tax	0	0	10,011	2,161	52,196	-257	2,170	1,756	-4,623	-2,098	-
YoY %	0.00%	0.00%	363.26%	-95.86%	20,409.73%	-111.84%	23.58%	137.98%	-120.35%	-	-
Horiz. %	0.00%	0.00%	-477.17%	-103.00%	-2,487.89%	12.25%	-103.43%	-83.70%	220.35%	100.00%	-
NP	-107,254	-135,117	-287,664	-305,385	-215,086	-120,552	-96,968	-88,206	-73,740	-29,188	15.54%
YoY %	20.62%	53.03%	5.80%	-41.98%	-78.42%	-24.32%	-9.93%	-19.62%	-152.64%	-	-
Horiz. %	367.46%	462.92%	985.56%	1,046.27%	736.90%	413.02%	332.22%	302.20%	252.64%	100.00%	-
Tax Rate	-	-	-	-	-	-	-	-	-	-	-
YoY %	-	-	-	-	-	-	-	-	-	-	-
Horiz. %	-	-	-	-	-	-	-	-	-	-	-
Total Cost	107,472	135,949	297,927	307,160	222,498	124,664	127,450	130,426	109,109	69,760	4.91%
YoY %	-20.95%	-54.37%	-3.01%	38.05%	78.48%	-2.19%	-2.28%	19.54%	56.41%	-	-
Horiz. %	154.06%	194.88%	427.07%	440.31%	318.95%	178.70%	182.70%	186.96%	156.41%	100.00%	-

	31/12/24	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	CAGR
Ratio Analysis
NP Margin	-49,254.27	-16,239.87	-2,803.13	-17,207.13	-2,902.17	-2,931.76	-318.12	-208.92	-208.49	-71.94	106.42%
YoY %	-203.29%	-479.35%	83.71%	-492.91%	1.01%	-821.59%	-52.27%	-0.21%	-189.81%	-	-
Horiz. %	68,465.76%	22,574.19%	3,896.48%	23,918.72%	4,034.15%	4,075.28%	442.20%	290.41%	289.81%	100.00%	-

	31/12/24	31/12/23	31/12/22	31/12/21	31/12/20	31/12/19	31/12/18	31/12/17	31/12/16	31/12/15	CAGR
Per Share
EPS	-3.95	-6.09	-14.47	-17.55	-16.64	-14.65	-1.05	-1.08	-1.01	-0.43	27.91%
YoY %	35.14%	57.91%	17.55%	-5.47%	-13.58%	-1,295.24%	2.78%	-6.93%	-134.88%	-	-
Horiz. %	918.60%	1,416.28%	3,365.12%	4,081.40%	3,869.77%	3,406.98%	244.19%	251.16%	234.88%	100.00%	-
EPS Diluted	-3.95	-6.09	-14.47	-17.55	-16.64	-14.65	-1.05	-1.08	-1.01	-0.43	27.91%
YoY %	35.14%	57.91%	17.55%	-5.47%	-13.58%	-1,295.24%	2.78%	-6.93%	-134.88%	-	-
Horiz. %	918.60%	1,416.28%	3,365.12%	4,081.40%	3,869.77%	3,406.98%	244.19%	251.16%	234.88%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 1 of 1 comments

selamba

so good counter

2013-08-05 20:11

Latest Videos